Furthermore, in the orthotopic glioma model with the GL261 cells, it has been reported that combination treatment can increase stem-like PD-1+TCF-1+CD8+ T cells, as well as their progeny, PD-1+TCF-1−, and effector CD8+ T cells. Here, CD8A is linked to central nervous system cancer.